BioCentury
ARTICLE | Clinical News

Caduet amlodipine besylate/atorvastatin calcium regulatory update

February 9, 2004 8:00 AM UTC

FDA granted marketing approval for Caduet to treat hypertension and hypercholesterolemia. Caduet combines hypertension drug Norvasc amlodipine besylate and cholesterol drug Lipitor atorvastatin, and will be available in multiple dosing combinations. ...